1 recruiting, 1 suspended. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Recruiting 1, Suspended 1 |
Follow Cardiac Fibrosis: new trials by email Literature Review of Cardiac Fibrosis trials Research Report on Cardiac Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis Inositol and alpha-lactalbumin - Metabolic Syndrome, Cardiac Fibrosis | Not applicable | Suspended | Lo.Li.Pharma s.r.l | 30 | 2022-12-23 | 2025-12-30 |
| Characterization of Heart Failure With Preserved Ejection Fraction cMR, biomarker - Heart Failure, Preserved Ejection Fraction, Cardiac Fibrosis | Not applicable | Recruiting | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 500 | 2014-12-04 | 2024-02-05 |
Heart Failure, Diastolic (1) · Metabolic Syndrome (1)
Cardiovascular Diseases (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Heart Failure (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Biomarkers (1) · Inositol (1) · Lactalbumin (1)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Lo.Li.Pharma s.r.l (1)
Belgium (1) · Italy (1)
Anne Catherine Pouleur (1) · Claudio Ferri, MD (1) · Davide Grassi, MD (1)